SCHEMBL29601148

SCHEMBL29601148

CC(=O)c1ccc(OCC(F)(F)F)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1I Q9P0X4 3/20 0.45
CACNA1G O43497 2/20 0.45
CACNA1H O95180 2/20 0.45
CNR2 P34972 2/20 0.45
KCNH2 Q12809 1/20 0.45
ALDH1A1 P00352 1/20 0.43
P4HTM Q9NXG6 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KDM4E B2RXH2 1/20 0.41
BACE1 P56817 3/20 0.41
BACE2 Q9Y5Z0 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
PAX8 Q06710 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27039792 1.00 CACNA1I (0.45) CACNA1ICACNA1GCACNA1HCNR2KCNH2
SCHEMBL21078914 0.89 P4HTM (0.41) CACNA1ICACNA1GCACNA1HCNR2KCNH2
SCHEMBL19992569 0.88 BACE1 (0.42) CACNA1ICACNA1GCACNA1HCNR2KCNH2
SCHEMBL287075 0.85 P4HTM (0.58) CACNA1ICACNA1GCACNA1HCNR2KCNH2
SCHEMBL286756 0.84 MAPK1 (0.53) CACNA1ICACNA1GCACNA1HCNR2KCNH2
SCHEMBL21920979 0.84 CACNA1I (0.40) CACNA1ICACNA1GCACNA1HCNR2KCNH2
SCHEMBL15994885 0.84 KMT2A (0.58) CACNA1ICACNA1GCACNA1HCNR2KCNH2
SCHEMBL15991475 0.83 ALDH1A1 (0.57) CACNA1ICACNA1GCACNA1HCNR2KCNH2
SCHEMBL21078924 0.83 CACNA1G (0.42) CACNA1ICACNA1GCACNA1HCNR2KCNH2
SCHEMBL2140228 0.82 NPC1 (0.50) CACNA1ICACNA1GCACNA1HCNR2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed